Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMEM106B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GIMAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUXAP10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MSANTD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IQGAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJB14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGEF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLHC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LACTB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBOAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IVNS1ABP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFE2L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on